Screener
aTyr Pharma ATYR Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's retained earnings?
- aTyr Pharma (ATYR) reported retained earnings of -$627.26M in Q2 2026.
- How has aTyr Pharma's retained earnings changed year-over-year?
- aTyr Pharma's retained earnings decreased by 10.7% year-over-year, from -$566.46M to -$627.26M.
- What is the long-term trend for aTyr Pharma's retained earnings?
- Over 5 years (2020 to 2025), aTyr Pharma's retained earnings has grown at a 12.4% compound annual growth rate (CAGR), from -$338.53M to -$606.16M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about aTyr Pharma's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude